Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04498455 · ClinicalTrials.gov registry record · Phase 4
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
A Phase 4 study of Metabolic Syndrome and Weight Gain Trajectory, sponsored by Baylor University.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04498455 is a Phase 4 study of Metabolic Syndrome and Weight Gain Trajectory that has completed, run by Baylor University. The registered enrollment target is 11 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04498455, a Phase 4 study of Metabolic Syndrome and Weight Gain Trajectory, has completed, sponsored by Baylor University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized placebo controlled trial to determine if increased dietary fiber will prevent weight gain, inhibit adiposity and reduce perceived stress levels in residents at the Waco Family Health Center as the result of changes in distal gut microbiota composition and function.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Prebiotin
Study Locations (1)
Texas
- Baylor University - Waco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-09-30 |
| Est. Completion | 2019-02-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04498455
The ClinicalTrials.gov registry entry for NCT04498455 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The listed sponsor is Baylor University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Prebiotin is the first listed.
NCT04498455 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04498455 about?
NCT04498455 is a clinical study titled "Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency". A randomized placebo controlled trial to determine if increased dietary fiber will prevent weight gain, inhibit adiposity and reduce perceived stress levels in residents at the Waco Family Health Center as the result of changes in distal gut microbiota composition and function.
What is the current status of trial NCT04498455?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2018-09-30. Estimated completion is 2019-02-15.
What conditions does trial NCT04498455 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Weight Gain Trajectory.
What interventions are being tested in trial NCT04498455?
The interventions under investigation include: Prebiotin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04498455?
This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04498455 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
RECRUITING · Phase 4
-
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
COMPLETED · Phase 4
-
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
COMPLETED · Phase 4
-
Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
COMPLETED · Phase 4
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.